Affinity of synthetic peptide fragments of MyoD for Id1 protein and their biological effects in several cancer cells

Journal of Peptide Science

Volumn 16, Issue 5, 2010, Pages 231-241

  Chen, Chiu Heng ^a   Kuo, Sheng Chu ^b   Huang, Li Jiau ^b   Hsu, Mei Hua ^b   Lung, Feng Di T ^a  

^a TUNGHAI UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antiproliferative agents; bHLH family; Cell cycle; Circular dicroism; Id1; MyoD; Peptide; Proliferation; Surface plasmon resonance

Indexed keywords

ANTINEOPLASTIC AGENT; HELIX LOOP HELIX PROTEIN; HETERODIMER; HISTIDYLALANYLLEUCYLLEUCYLARGINYLASPARTYLGLUTAMINAMIDE; HISTIDYLLEUCYLGLUTAMINYLHISTIDYLVALYLISOLEUCYLGLUTAMYLGLYCYLLEUCYLGLUTAMINYLALANYLLEUCYLLEUCYLARGINYLASPARTYLGLUTAMINYLCYSTEINAMIDE; HISTIDYLLYSYLVALYLGLUTAMYLISOLEUCYLLEUCYLGLUTAMINYLHISTIDYLVALYLISOLEUCYLASPARTYLTYROSYLISOLEUCYLGLUTAMYLGLYCYLLEUCYLGLUTAMINYLALANYLLEUCYLLEUCYLARGINYLASPARTYLGLUTAMINAMIDE; HISTIDYLTYROSINEISOLEUCYLGLUTAMYLGLYCYLLEUCYLGLUTAMINYLALANYLLEUCYLARGINYLASPARTYLGLUTAMINAMIDE; INHIBITOR OF DIFFERENTIATION 1; MYOD PROTEIN; PEPTIDE FRAGMENT; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CIRCULAR DICHROISM; COLON CANCER; CONTROLLED STUDY; DNA BINDING; DRUG PROTEIN BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; SURFACE PLASMON RESONANCE;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CIRCULAR DICHROISM; FLOW CYTOMETRY; HT29 CELLS; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MYOD PROTEIN; PEPTIDE FRAGMENTS;

EID: 77951139335     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1216     Document Type: Article

References (42)

1. Barone MV, Pepperkok R, Peverali FA, Philipson L. Id proteins control growth induction in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 1994; 91: 4985-4988. (Pubitemid 24177775)
2. Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H, Oda K. Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J. Biol. Chem. 1994; 269: 2139-2145. (Pubitemid 24035425)
3. Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K, Benezra R. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 1999; 401: 670-677. (Pubitemid 129515750)
4. Mori S, Nishikawa SI, Yokota Y. Lactation defect in mice lacking the helix-loop-helix inhibitor Id2. Embo J. 2000; 19: 5772-5781.
5. Iavarone A, Garg P, Lasorella A, Hsu J, Israel MA. The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev. 1994; 8: 1270-1284. (Pubitemid 24181319)
6. Lasorella A, Uo T, Iavarone A. Id proteins at the cross-road of development and cancer. Oncogene 2001; 20: 8326-8333.
7. Norton JD. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 2000; 113(Pt 22): 3897-3905. (Pubitemid 32194515)
8. Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM. Id proteins in cell growth and tumorigenesis. Cancer Cell 2003; 3: 525-530.
9. Coppe JP, Smith AP, Desprez PY. Id proteins in epithelial cells. Exp. Cell Res. 2003; 285: 131-145.
10. Zebedee Z, Hara E. Id proteins in cell cycle control and cellular senescence. Oncogene 2001; 20: 8317-8325. (Pubitemid 34121902)
11. Ruzinova MB, Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell Biol. 2003; 13: 410-418. (Pubitemid 36897645)
12. Alani RM, Hasskarl J, Grace M, Hernandez MC, Israel MA, Munger K. Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc. Natl. Acad. Sci. U.S.A. 1999; 96: 9637-9641. (Pubitemid 29398784)
13. Fong S, Debs RJ, Desprez PY. Id genes and proteins as promising targets in cancer therapy. Trends Mol. Med. 2004; 10: 387-392. (Pubitemid 39061140)
14. Iavarone A, Lasorella A. ID proteins as targets in cancer and tools in neurobiology. Trends Mol. Med. 2006; 12: 588-594. (Pubitemid 44780202)
15. Kim H, Chung H, Kim HJ, Lee JY, Oh MY, Kim Y, Kong G. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells. Breast Cancer Res. Treat. 2008; 112: 287-296.
16. Meteoglu I, Meydan N, Erkus M. Id-1: regulator of EGFR and VEGF and potential target for colorectal cancer therapy. J. Exp. Clin. Cancer Res. 2008; 27: 69.
17. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 1990; 61: 49-59. (Pubitemid 20134378)
18. Christy BA, Sanders LK, Lau LF, Copeland NG, Jenkins NA, Nathans D. An Id-related helix-loop-helix protein encoded by a growth factor-inducible gene. Proc. Natl. Acad. Sci. U.S.A. 1991; 88: 1815-1819. (Pubitemid 21916317)
19. Jen Y, Manova K, Benezra R. Expression patterns of Id1, Id2, and Id3 are highly related but distinct from that of Id4 during mouse embryogenesis. Dev. Dyn. 1996; 207: 235-252. (Pubitemid 26378326)
20. Jen Y, Manova K, Benezra R. Each member of the Id gene family exhibits a unique expression pattern in mouse gastrulation and neurogenesis. Dev. Dyn. 1997; 208: 92-106. (Pubitemid 27030487)
21. Moldes M, Boizard M, Liepvre XL, Feve B, Dugail I, Pairault J. Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) transfactors for the regulation of fatty acid synthase promoter in adipocytes. Biochem. J. 1999; 344(Pt 3): 873-880. (Pubitemid 30032537)
22. Roberts EC, Deed RW, Inoue T, Norton JD, Sharrocks AD. Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding. Mol. Cell. Biol. 2001; 21: 524-533. (Pubitemid 32037372)
23. Perk J, Iavarone A, Benezra R. Id family of helix-loop-helix proteins in cancer. Nat. Rev. Cancer 2005; 5: 603-614.
24. Henke E, Perk J, Vider J, de Candia P, Chin Y, Solit DB, Ponomarev V, Cartegni L, Manova K, Rosen N, Benezra R. Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo. Nat. Biotechnol. 2008; 26: 91-100.
25. Lung FD, Tsai JY, Wei SY, Cheng JW, Chen C, Li P, Roller PP. Novel peptide inhibitors for Grb2 SH2 domain and their detection by surface plasmon resonance. J. Pept. Res. 2002; 60: 143-149. (Pubitemid 34983486)
26. Merrifield RB. Solid-phase peptide synthesis. Adv. Enzymol. Relat. Areas Mol. Biol. 1969; 32: 221-296.
27. Lung FD, Chen HY, Lin HT. Monitoring bone loss using ELISA and surface plasmon resonance (SPR) technology. Protein Pept. Lett. 2003; 10: 313-319.
28. Lung FD, Tsai JY. Grb2 SH2 domain-binding peptide analogs as potential anticancer agents. Biopolymers 2003; 71: 132-140.
29. Fairman R, Beran-Steed RK, Anthony-Cahill SJ, Lear JD, Stafford WF 3rd, DeGrado WF, Benfield PA, Brenner SL. Multiple oligomeric states regulate the DNA binding of helix-loop-helix peptides. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 10429-10433. (Pubitemid 23347055)
30. Pesce S, Benezra R. The loop region of the helix-loop-helix protein Id1 is critical for its dominant negative activity. Mol. Cell. Biol. 1993; 13: 7874-7880. (Pubitemid 23354312)
31. Perez-Iratxeta C, Andrade-Navarro MA. K2D2: estimation of protein secondary structure from circular dichroism spectra. BMC Struct. Biol. 2008; 8: 25. (Pubitemid 351749368)
32. Wilson JW, Deed RW, Inoue T, Balzi M, Becciolini A, Faraoni P, Potten CS, Norton JD. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. Cancer Res. 2001; 61: 8803-8810. (Pubitemid 34013894)
33. Jan YN, Jan LY. Functional gene cassettes in development. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 8305-8307.
34. Neuhold LA, Wold B. HLH forced dimers: tethering MyoD to E47 generates a dominant positive myogenic factor insulated from negative regulation by Id. Cell 1993; 74: 1033-1042.
35. Quesenberry PJ, Iscove NN, Cooper C, Brady G, Newburger PE, Stein GS, Stein JS, Reddy GP, Pearson-White S. Expression of basic helix-loop-helix transcription factors in explant hematopoietic progenitors. J. Cell. Biochem. 1996; 61: 478-488.
36. Spicer DB, Rhee J, Cheung WL, Lassar AB. Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist. Science 1996; 272: 1476-1480.
37. Lingbeck JM, Trausch-Azar JS, Ciechanover A, Schwartz AL. In vivo interactions of MyoD, Id1, and E2A proteins determined by acceptor photobleaching fluorescence resonance energy transfer. FASEB J. 2008; 22: 1694-1701.
38. Fong S, Itahana Y, Sumida T, Singh J, Coppe JP, Liu Y, Richards PC, Bennington JL, Lee NM, Debs RJ, Desprez PY. Id-1 as a molecular target in therapy for breast cancer cell invasion andmetastasis. Proc. Natl. Acad. Sci. U.S.A. 2003; 100: 13543-13548.
39. Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J, Desprez PY. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res. 2000; 60: 1332-1340.
40. Schoppmann SF, Schindl M, Bayer G, Aumayr K, Dienes J, Horvat R, Rudas M, Gnant M, Jakesz R, Birner P. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int. J. Cancer 2003; 104: 677-682.
41. Gupta GP, Perk J, Acharyya S, de Candia P, Mittal V, Todorova-Manova K, Gerald WL, Brogi E, Benezra R, Massague J. ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc. Natl. Acad. Sci. U.S.A. 2007; 104: 19506-19511.
42. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J. Genes that mediate breast cancer metastasis to lung. Nature 2005; 436: 518-524.